MUSCULOSKELETAL
Autologous cellular implants for orthopedic and musculoskeletal therapies
PROVEN EFFECTIVE
MINIMALLY INVASIVE
PENDING FDA APPROVAL
EASY AND ACCESSIBLE
FROM THE PAINFUL PRESENT TO A LESS INVASIVE FUTURE
Conventional treatment of osteoarthritis begins with physical therapy, weight loss, and over-the-counter anti-inflammatory drugs. As the severity of symptoms increase, so does the treatment, requiring multiple steroid injections or use of hyaluronic acid injections. These treatments mask the pain of osteoarthritis but do nothing to slow its progression or reverse the underlying causes. Eventually, many patients resort to total joint replacement—a significant surgical procedure with significant cost.
The SVF-2 presents an exciting new way to treat osteoarthritis with cellular medicine. Rather than masking symptoms of osteoarthritis, this process uses the patientʼs own cells to create a healing environment within their body. The goal is to ultimately enable the bodyʼs innate healing intelligence to repair damage, eliminate or significantly reduce pain, and prevent further deterioration.
THE PROCESS IS SIMPLE
01
EXTRACT
Using the SVF-2, a small sample of adipose tissue is extracted from the patient.
02
WASH
Using the SVF-2, the adipose tissue is washed to remove red cells and other contaminants.
03
ISOLATE
From that tissue, we isolate a heterogenous mixture of the essential stromal and vascular cells that enable natural tissue repair and regeneration.
04
INJECT
The autologous cellular implant is then extracted from the SVF-2 device and then reintroduced into the body at site of damage.
In the most severe cases of osteoarthritis, joint replacement may still be required, but for many, this process presents a long-term, non-surgical, regenerative solution.
BLOG
Beyond drugs and Surgery: changing medicine as we know it
As a company committed to proving the promise of regenerative medicine, GID continues to evaluate applications of its SVF-2 cellular implant platform clinically. One such application is the treatment of…
BLOG
Initial safety and feasibility of cellular therapy
Companies and clinics tout the promise of cellular therapy (usually as a “stem cell therapy”) backed by little more than anecdotal evidence and the hypothetical possibility of efficacy. When we…
BLOG
Interventional orthopedics and cell based therapy
A total knee replacement involves hours of surgery, a metal/polymer implant, and months of recovery. We prefer a minimally invasive approach that uses an injection instead of surgery, a cellular…
MUSCULOSKELETAL
Autologous cellular implants for orthopedic and musculoskeletal therapies
PROVEN EFFECTIVE
MINIMALLY INVASIVE
PENDING FDA APPROVAL
EASY AND ACCESSIBLE
FROM THE PAINFUL PRESENT TO A LESS INVASIVE FUTURE
Conventional treatment of osteoarthritis begins with physical therapy, weight loss, and over-the-counter anti-inflammatory drugs. As the severity of symptoms increase, so does the treatment, requiring multiple steroid injections or use of hyaluronic acid injections. These treatments mask the pain of osteoarthritis but do nothing to slow its progression or reverse the underlying causes. Eventually, many patients resort to total joint replacement—a significant surgical procedure with significant cost.
The SVF-2 presents an exciting new way to treat osteoarthritis with cellular medicine. Rather than masking symptoms of osteoarthritis, this process uses the patientʼs own cells to create a healing environment within their body. The goal is to ultimately enable the bodyʼs innate healing intelligence to repair damage, eliminate or significantly reduce pain, and prevent further deterioration.
THE PROCESS IS SIMPLE
01
EXTRACT
Using the SVF-2, a small sample of adipose tissue is extracted from the patient.
02
WASH
Using the SVF-2, the adipose tissue is washed to remove red cells and other contaminants.
03
ISOLATE
From that tissue, we isolate a heterogenous mixture of the essential stromal and vascular cells that enable natural tissue repair and regeneration.
04
INJECT
The autologous cellular implant is then extracted from the SVF-2 device and then reintroduced into the body at site of damage.
In the most severe cases of osteoarthritis, joint replacement may still be required, but for many, this process presents a long-term, non-surgical, regenerative solution.
BLOG
Beyond drugs and Surgery: changing medicine as we know it
As a company committed to proving the promise of regenerative medicine, GID continues to evaluate applications of its SVF-2 cellular implant platform clinically. One such application is the treatment of…
BLOG
Initial safety and feasibility of cellular therapy
Companies and clinics tout the promise of cellular therapy (usually as a “stem cell therapy”) backed by little more than anecdotal evidence and the hypothetical possibility of efficacy. When we…
BLOG
Interventional orthopedics and cell based therapy
A total knee replacement involves hours of surgery, a metal/polymer implant, and months of recovery. We prefer a minimally invasive approach that uses an injection instead of surgery, a cellular…
